Sanofi-Aventis’ U.S. operations expand support for underinsured to receive health care
BRIDGEWATER, N.J. The United States subsidiary of Sanofi-Aventis announced Monday that starting Jan. 1, it will increase access to its Patient Assistance Programs to include uninsured patients with incomes up to 250 percent of the federal poverty level.
Sanofi said the PAPs, which will not include cancer drugs, assist low-income patients in gaining access to the company’s prescription medications by focusing on individual patients and acting as a resource for them and their advocates.
“Sanofi-Aventis U.S. remains committed to making our prescription medicines available to uninsured and low-income patients through our PAPs,” Sanofi-Aventis president and chief executive officer Greg Irace said in a statement. “We have taken several steps to help patients with the greatest financial need access these medications.”
The PAPs include medicines for diabetes, rheumatoid arthritis, blood-clotting problems, allergies, skin disorders and urological disorders.
Gilead sues Teva over approval application for generic Truvada
NEW YORK Gilead Sciences has filed a lawsuit against Israeli generic drug maker Teva Pharmaceutical Industries and a subsidiary.
Gilead, which filed the suit Friday in a United States District Court in New York, alleged that Teva committed patent infringement when it filed an approval application with the Food and Drug Administration for a generic version of Truvada (emtricitabine), a drug for treating HIV.
Gilead has a license to manufacture and sell the drug from Emory University in Atlanta.
Take Care adds another clinic to its network in Miami/Fort Lauderdale area
CONSHOHOCKEN, Pa. Take Care Health Systems, which is owned by Walgreens, has opened one new clinic in the Miami/South Fort Lauderdale area. The opening marks the 10th Take Care Clinic in the market.
The company currently operates 313 clinics in 18 states.